111 related articles for article (PubMed ID: 28781795)
1. Transmembrane channel-like protein 8 as a potential biomarker for poor prognosis of hepatocellular carcinoma.
Lu P; Ding Q; Ding S; Fan Y; Li X; Tian D; Liu M
Mol Clin Oncol; 2017 Aug; 7(2):244-248. PubMed ID: 28781795
[TBL] [Abstract][Full Text] [Related]
2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
3. NEK2 serves as a prognostic biomarker for hepatocellular carcinoma.
Li G; Zhong Y; Shen Q; Zhou Y; Deng X; Li C; Chen J; Zhou Y; He M
Int J Oncol; 2017 Feb; 50(2):405-413. PubMed ID: 28101574
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive co-expression analysis reveals TMC8 as a prognostic immune-associated gene in head and neck squamous cancer.
Lin B; Wang S; Yao Y; Shen Y; Yang H
Oncol Lett; 2021 Jul; 22(1):498. PubMed ID: 33981360
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of microRNA-32 is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma.
Yang H; Li Y; Zhong X; Luo P; Luo P; Sun R; Xie R; Fu D; Ma Y; Cong X; Li W
Oncol Lett; 2018 Apr; 15(4):4097-4104. PubMed ID: 29541175
[TBL] [Abstract][Full Text] [Related]
6. Cytoskeleton-associated membrane protein 4 is upregulated in tumor tissues and is associated with clinicopathological characteristics and prognosis in hepatocellular carcinoma.
Chen ZY; Wang T; Gan X; Chen SH; He YT; Wang YQ; Zhang KH
Oncol Lett; 2020 Jun; 19(6):3889-3898. PubMed ID: 32382336
[TBL] [Abstract][Full Text] [Related]
7. High KIAA1522 expression predicts a poor prognosis in patients with hepatocellular carcinoma.
Xu Y; Sun C; Han B; Xi Y; Zhang M; Yang J; Chen Z
Oncol Lett; 2020 Jul; 20(1):509-516. PubMed ID: 32565976
[TBL] [Abstract][Full Text] [Related]
8. SYPL1 overexpression predicts poor prognosis of hepatocellular carcinoma and associates with epithelial-mesenchymal transition.
Chen DH; Wu QW; Li XD; Wang SJ; Zhang ZM
Oncol Rep; 2017 Sep; 38(3):1533-1542. PubMed ID: 28731154
[TBL] [Abstract][Full Text] [Related]
9. Association between the overexpression of PBOV1 and the prognosis of patients with hepatocellular carcinoma.
Xue C; Zhong Z; Ye S; Wang Y; Ye Q
Oncol Lett; 2018 Sep; 16(3):3401-3407. PubMed ID: 30127941
[TBL] [Abstract][Full Text] [Related]
10. Elevated DSN1 expression is associated with poor survival in patients with hepatocellular carcinoma.
Sun C; Huang S; Ju W; Hou Y; Wang Z; Liu Y; Wu L; He X
Hum Pathol; 2018 Nov; 81():113-120. PubMed ID: 30136646
[TBL] [Abstract][Full Text] [Related]
11. CIP2A is highly expressed in hepatocellular carcinoma and predicts poor prognosis.
He H; Wu G; Li W; Cao Y; Liu Y
Diagn Mol Pathol; 2012 Sep; 21(3):143-9. PubMed ID: 22847158
[TBL] [Abstract][Full Text] [Related]
12. High expression of myofibrillogenesis regulator-1 predicts poor prognosis for patients with hepatocellular carcinoma after curative hepatectomy.
Wang C; Xiang H; Si H; Guo D; Sun M
Int J Clin Exp Pathol; 2015; 8(11):14818-23. PubMed ID: 26823810
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
14. Mastermind-like Transcriptional Coactivator 1 Overexpression Predicts Poor Prognosis in Human with Hepatocellular Carcinoma.
Wang J; Zhang SM; Wu JM; Lu ZC; Yang JR; Wu HS; Chen H; Lin B; Xu RH; Cao TS
Ann Clin Lab Sci; 2016 Sep; 46(5):502-7. PubMed ID: 27650617
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma.
Wang R; Yu Z; Chen F; Liao C; Wang Q; Huang X
Hum Pathol; 2018 Mar; 73():114-121. PubMed ID: 29288040
[TBL] [Abstract][Full Text] [Related]
16. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
18. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084
[TBL] [Abstract][Full Text] [Related]
20. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
Zheng H; Yang Y; Wang MC; Yuan SX; Tian T; Han J; Ni JS; Wang J; Xing H; Zhou WP
Surg Oncol; 2016 Sep; 25(3):171-7. PubMed ID: 27566019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
